Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?

Author:

Maccarrone Mauro12ORCID,Maldonado Rafael3,Casas Miguel456,Henze Thomas7,Centonze Diego8

Affiliation:

1. Department of Medicine, Campus Bio-Medico University of Rome , Rome, Italy

2. Laboratory of Lipid Neurochemistry, European Center for Brain Research/IRCCS Santa Lucia Foundation , Rome, Italy

3. Laboratori de Neurofarmacologia, Departament de Ciències Experimentals i de la Salut (CEXS), Facultat de Ciències de la Salut i de la Vida, Universitat Pompeu Fabra , Barcelona, Spain

4. Servicio de Psiquiatría, Hospital Universitari Vall d’Hebron , Barcelona, Spain

5. Departamento de Psiquiatría y Medicina Legal, Universitat Autònoma de Barcelona , Barcelona, Spain

6. CIBERSAM , Barcelona, Spain

7. Passauer Wolf Reha-Zentrum Nittenau , Nittenau, Germany

8. Multiple Sclerosis Clinical and Research Center, Tor Vergata University, Rome & Unit of Neurology, IRCCS Istituto Neurologico Mediterraneo Neuromed , Pozzilli, Italy

Funder

Almirall S.A

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3